
Pawsperity Biotechnologies is a biotechnology company focused on advancing precision health for companion animals through innovative molecular profiling and AI-driven diagnostics. They develop accurate, actionable testing technologies that enable earlier and more precise diagnosis, improved therapy monitoring, and better health outcomes for pets. Their approach integrates genomics, proteomics, metabolomics, epigenetics, and clinical data with machine learning to create high-resolution health and disease fingerprints unique to each animal. The company leverages extensive experience in molecular diagnostics from human medicine to address chronic animal diseases like kidney failure, heart disease, and diabetes. Headquartered in Vancouver, Canada, Pawsperity collaborates across sectors to enhance veterinary health solutions.

Pawsperity Biotechnologies is a biotechnology company focused on advancing precision health for companion animals through innovative molecular profiling and AI-driven diagnostics. They develop accurate, actionable testing technologies that enable earlier and more precise diagnosis, improved therapy monitoring, and better health outcomes for pets. Their approach integrates genomics, proteomics, metabolomics, epigenetics, and clinical data with machine learning to create high-resolution health and disease fingerprints unique to each animal. The company leverages extensive experience in molecular diagnostics from human medicine to address chronic animal diseases like kidney failure, heart disease, and diabetes. Headquartered in Vancouver, Canada, Pawsperity collaborates across sectors to enhance veterinary health solutions.